These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 39377541)

  • 1. EphA-Mediated Regulation of Stomatin Expression in Prostate Cancer Cells.
    Nishida M; Sato A; Shimizu A; Rahman NIA; Wada A; Kageyama S; Ogita H
    Cancer Med; 2024 Oct; 13(19):e70276. PubMed ID: 39377541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stomatin-Mediated Inhibition of the Akt Signaling Axis Suppresses Tumor Growth.
    Rahman NIA; Sato A; Tsevelnorov K; Shimizu A; Komeno M; Ahmat Amin MKB; Molla MR; Soh JEC; Nguyen LKC; Wada A; Kawauchi A; Ogita H
    Cancer Res; 2021 May; 81(9):2318-2331. PubMed ID: 33757977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment.
    Sato A; Rahman NIA; Shimizu A; Ogita H
    Cancer Sci; 2021 Oct; 112(10):4005-4012. PubMed ID: 34420253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression.
    Li S; Wu Z; Ma P; Xu Y; Chen Y; Wang H; He P; Kang Z; Yin L; Zhao Y; Zhang X; Xu X; Ma X; Guan M
    Cell Death Dis; 2017 Oct; 8(10):e3122. PubMed ID: 29022918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphA family gene expression in the developing mouse neocortex: regional patterns reveal intrinsic programs and extrinsic influence.
    Yun ME; Johnson RR; Antic A; Donoghue MJ
    J Comp Neurol; 2003 Feb; 456(3):203-16. PubMed ID: 12528186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model.
    Bhatia S; Hirsch K; Baig NA; Rodriguez O; Timofeeva O; Kavanagh K; Lee YC; Wang XJ; Albanese C; Karam SD
    J Hematol Oncol; 2015 Sep; 8():105. PubMed ID: 26345456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.
    Rosati R; Patki M; Chari V; Dakshnamurthy S; McFall T; Saxton J; Kidder BL; Shaw PE; Ratnam M
    J Biol Chem; 2016 Dec; 291(50):25983-25998. PubMed ID: 27793987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells.
    Sharfe N; Freywald A; Toro A; Roifman CM
    J Immunol; 2003 Jun; 170(12):6024-32. PubMed ID: 12794130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway.
    Xie W; Li S; Guo H; Zhang J; Tu M; Wang R; Lin B; Wu Y; Wang X
    Cancer Med; 2023 Jul; 12(14):15317-15336. PubMed ID: 37326412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation.
    Sen A; De Castro I; Defranco DB; Deng FM; Melamed J; Kapur P; Raj GV; Rossi R; Hammes SR
    J Clin Invest; 2012 Jul; 122(7):2469-81. PubMed ID: 22684108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.
    Oh YT; Liu X; Yue P; Kang S; Chen J; Taunton J; Khuri FR; Sun SY
    J Biol Chem; 2010 Dec; 285(53):41310-9. PubMed ID: 21044953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling.
    Lawrenson ID; Wimmer-Kleikamp SH; Lock P; Schoenwaelder SM; Down M; Boyd AW; Alewood PF; Lackmann M
    J Cell Sci; 2002 Mar; 115(Pt 5):1059-72. PubMed ID: 11870224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine.
    Kawahara T; Aljarah AK; Shareef HK; Inoue S; Ide H; Patterson JD; Kashiwagi E; Han B; Li Y; Zheng Y; Miyamoto H
    Prostate; 2016 Jun; 76(8):744-56. PubMed ID: 26864615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells.
    Patki M; Chari V; Sivakumaran S; Gonit M; Trumbly R; Ratnam M
    J Biol Chem; 2013 Apr; 288(16):11047-65. PubMed ID: 23426362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM10-cleaved ephrin-A5 contributes to prostate cancer metastasis.
    Cai C; Zhang M; Liu L; Zhang H; Guo Y; Lan T; Xu Y; Ma P; Li S
    Cell Death Dis; 2022 May; 13(5):453. PubMed ID: 35551177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphA5 and EphA7 forward signaling enhances human hematopoietic stem and progenitor cell maintenance, migration, and adhesion via Rac1 activation.
    Nguyen TM; Arthur A; Zannettino AC; Gronthos S
    Exp Hematol; 2017 Apr; 48():72-78. PubMed ID: 27988259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neural Cell Adhesion Molecule (NCAM) Promotes Clustering and Activation of EphA3 Receptors in GABAergic Interneurons to Induce Ras Homolog Gene Family, Member A (RhoA)/Rho-associated protein kinase (ROCK)-mediated Growth Cone Collapse.
    Sullivan CS; Kümper M; Temple BS; Maness PF
    J Biol Chem; 2016 Dec; 291(51):26262-26272. PubMed ID: 27803162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.
    Vail ME; Murone C; Tan A; Hii L; Abebe D; Janes PW; Lee FT; Baer M; Palath V; Bebbington C; Yarranton G; Llerena C; Garic S; Abramson D; Cartwright G; Scott AM; Lackmann M
    Cancer Res; 2014 Aug; 74(16):4470-81. PubMed ID: 25125683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
    Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
    Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA3, induced by PC-1/PrLZ, contributes to the malignant progression of prostate cancer.
    Wu R; Wang H; Wang J; Wang P; Huang F; Xie B; Zhao Y; Li S; Zhou J
    Oncol Rep; 2014 Dec; 32(6):2657-65. PubMed ID: 25231727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.